← 返回前沿论文

探讨成纤维细胞激活蛋白α阳性癌症相关成纤维细胞与肿瘤微环境在癌症免疫治疗背景下的复杂相互作用

英文原题:Investigating the complex interplay between fibroblast activation protein α-positive cancer associated fibroblasts and the tumor microenvironment in the context of cancer immunotherapy.

PubMed 2024/07/05(内容时间) Front Immunol Q1 · IF 7(JCR 2025)

研究概要

这些发现强调了肿瘤生物学的复杂性以及个性化治疗和患者富集策略的必要性。从FAP+CAF患病率、免疫浸润和基因特征中获得的见解为肿瘤微环境提供了宝贵的视角,有助于未来的研究和临床策略制定。

研究思路结论见上方概要

本研究探讨了成纤维细胞活化蛋白(FAP)阳性癌症相关成纤维细胞(FAP+CAF)在塑造肿瘤免疫微环境中的作用,重点关注其与免疫细胞功能及细胞因子表达模式的关联。

利用免疫组织化学技术,我们观察到转移性肾细胞癌(RCC)肿瘤中FAP+CAF密度高于原发性肿瘤,且较高的FAP+CAF与RCC中T细胞浸润增加相关,这一独特现象揭示了肿瘤进展、FAP+CAF密度与免疫反应之间复杂的相互作用。

对FAP+CAF富集基质区域中免疫细胞亚群的分析进一步揭示了FAP+基质与多种T细胞类型之间的显著相关性,尤其是在RCC和非小细胞肺癌(NSCLC)中。转录组分析对此进行了补充,扩展了所 interrogated 的基质和免疫细胞亚群范围,以及额外的肿瘤类型。这使得能够评估这些亚群与肿瘤浸润、肿瘤血管化及肿瘤微环境其他组分的关联。我们的综合研究还涵盖了不同癌症类型中的细胞因子、血管生成和炎症基因特征,揭示了异质性的细胞组成、细胞因子表达和血管生成谱。通过细胞因子通路分析,我们探索了FAP+CAF密度与免疫细胞状态之间的关系,揭示了可能限制肿瘤驻留免疫细胞抗肿瘤活性的潜在免疫抑制回路。

展开英文摘要原文

INTRODUCTION: This study investigates the role of Fibroblast Activation Protein (FAP)-positive cancer-associated fibroblasts (FAP+CAF) in shaping the tumor immune microenvironment, focusing on its association with immune cell functionality and cytokine expression patterns. METHODS: Utilizing immunohistochemistry, we observed elevated FAP+CAF density in metastatic versus primary renal cell carcinoma (RCC) tumors, with higher FAP+CAF correlating with increased T cell infiltration in RCC, a unique phenomenon illustrating the complex interplay between tumor progression, FAP+CAF density, and immune response. RESULTS: Analysis of immune cell subsets in FAP+CAF-rich stromal areas further revealed significant correlations between FAP+ stroma and various T cell types, particularly in RCC and non-small cell lung cancer (NSCLC). This was complemented by transcriptomic analyses, expanding the range of stromal and immune cell subsets interrogated, as well as to additional tumor types. This enabled evaluating the association of these subsets with tumor infiltration, tumor vascularization and other components of the tumor microenvironment. Our comprehensive study also encompassed cytokine, angiogenesis, and inflammation gene signatures across different cancer types, revealing heterogeneous cellular composition, cytokine expressions and angiogenic profiles. Through cytokine pathway profiling, we explored the relationship between FAP+CAF density and immune cell states, uncovering potential immunosuppressive circuits that limit anti-tumor activity in tumor-resident immune cells. CONCLUSIONS: These findings underscore the complexity of tumor biology and the necessity for personalized therapeutic and patient enrichment approaches. The insights gathered from FAP+CAF prevalence, immune infiltration, and gene signatures provide valuable perspectives on tumor microenvironments, aiding in future research and clinical strategy development.

论文信息

作者
Kraxner A、Braun F、Cheng WY、Yang TO、Pipaliya S、Canamero M、Andersson E、Harring SV
第一作者单位
Roche Pharma Research and Early Development, Oncology, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Basel, Switzerland.Switzerland
通讯作者单位
Roche Pharma Research and Early Development, Oncology, Roche Innovation Center Zurich, Roche Glycart AG, Schlieren, Switzerland.Switzerland
期刊
Frontiers in immunology2024
原文标识
PubMed 39035007 · DOI 10.3389/fimmu.2024.1352632